Dr. Nickmans - Dr. Morren SRL
Dr. Nickmans - Dr. Morren reported total assets of €1.96m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Dr. Nickmans - Dr. Morren shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +65 % Total assets +35 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Nickmans - Dr. Morren's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
Dr. Nickmans - Dr. Morren's financial analysis
- Solvency95.2%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Nickmans - Dr. Morren
Dr. Nickmans - Dr. Morren's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0446.330.355
- VAT number
- BE0446330355
- Peppol
- Registered · 0208:0446330355 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jan 1992
- Registered office
- 3470 Kortenaken
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- General medical practice activities (NACE 86210)
Dr. Nickmans - Dr. Morren (SRL) has been based in Kortenaken since 1992, active in: general medical practice activities. For 2025, it reports a net profit of 271,823 € and equity of €1.86m; its revenue is not published. Its solvency stands at 95.2%, above the median of its sector (72.4%).
Companies similar to Dr. Nickmans - Dr. Morren
Companies in the same business, of comparable size and area, outside its group.
- Dr. Vanhauwaert D. General medical practice activities Zonnebeke · balance sheet €1.95m
- DRS. Vercaemer-Vanneste General medical practice activities Wervik · balance sheet €2.00m
- Dokter Langsweirdt Dirk General medical practice activities Harelbeke · balance sheet €2.29m
- DR.JAN Verschuere General medical practice activities Wevelgem · balance sheet €2.30m
- Venuc General medical practice activities Bruges · balance sheet €1.60m
- Artsenhuis Posthoorn General medical practice activities Wevelgem · balance sheet €2.44m
- DR. Verhelst Griet General medical practice activities Lendelede · balance sheet €1.51m
- Huisarts Stefan Devos General medical practice activities Ledegem · balance sheet €1.41m
Frequently asked questions about Dr. Nickmans - Dr. Morren
What is the revenue of Dr. Nickmans - Dr. Morren?
Dr. Nickmans - Dr. Morren files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Nickmans - Dr. Morren?
In Belgium, the VAT number is the company number prefixed with BE: BE0446330355 for Dr. Nickmans - Dr. Morren, if the company is VAT-registered. Its company number (CBE) is 0446.330.355.
Where is the registered office of Dr. Nickmans - Dr. Morren?
According to the CBE register, the registered office of Dr. Nickmans - Dr. Morren is in 3470 Kortenaken.
What is the equity of Dr. Nickmans - Dr. Morren?
At the close of the 2025 financial year, the equity of Dr. Nickmans - Dr. Morren amounts to 1,863,490 €, a solvency of 95.2% of total assets.
Who manages Dr. Nickmans - Dr. Morren?
The register lists 2 active mandates at Dr. Nickmans - Dr. Morren. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Nickmans - Dr. Morren
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →